Premium
Immunological investigations of Candida albicans in respiratory disease.
Author(s) -
Edge G,
Longbottom JL,
Tee RD,
Pepys J
Publication year - 1977
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1977.tb04526.x
Subject(s) - candida albicans , precipitin , mannan , medicine , corpus albicans , immunology , radioallergosorbent test , antibody , antigen , incidence (geometry) , respiratory system , immunoglobulin e , antiserum , microbiology and biotechnology , biology , polysaccharide , biochemistry , physics , optics
1. Tests against rabbit antiserum to Candida albicans showed about 40 protein antigens in cytoplasmic extract compared with two in a commercial test extract, which contained mainly polysaccharide (mannan) antigens. 2. Positive precipitin tests to the mannan preparation were recorded in 40% of 56 asthmatics on systemic corticosteroids and 37% of 56 rhinitis patients not so treated. The titres were slightly higher in the corticosteroid group. There was no increase in precipitins over 0‐9 months in asthmatics treated with beclomethasone dipropionate aerosol (BDA) by inhalation, or over 0‐12 months in rhinitis patients treated with BDA nasal spray. No positive reactions to the purified protein fraction were recorded. 3. Radioallergosorbent tests for specific IgE antibody showed a higher incidence of positive results with whole C. albicans yeast cells than with purified cytoplasmic protein. There was a higher incidence of positive results to protein in patients on systemic corticosteroids than in the other patients. No change in incidence occurred in asthmatics on BDA. The number of positive results in 56 rhinitis patients increased on BDA from 28 to 37 for yeast cells, and from 7 to 16 for cytoplasmic protein. This was attributed to C. albicans challenge tests. 4. Specific IgA antibodies to yeast cells were detected in 48/56 asthmatics on systemic corticosteroids, and there were no significant changes over 0‐9 months on BDA. The corresponding figures for rhinitis patients were 25/56, and again there were no significant changes over 0‐12 months on BDA.